MedPath
NMPA Approval

Aztreonam for Injection

国药准字H20123111

December 31, 2021

国药准字H20123111

Drug Information

注射用氨曲南

注射剂

0.5g(按C13H17N5O8S2计算)

化学药品

December 31, 2021

Company Information

Applicant Company

海南省海口市保税区A06-2

Manufacturing Company

海南省海口市保税区A06-2

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用氨曲南 - NMPA 批准文号 | MedPath